These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19497954)

  • 1. Histone-acetylated control of fibroblast growth factor receptor 2 intron 2 polymorphisms and isoform splicing in breast cancer.
    Zhu X; Asa SL; Ezzat S
    Mol Endocrinol; 2009 Sep; 23(9):1397-405. PubMed ID: 19497954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analysis of a breast cancer-associated FGFR2 single nucleotide polymorphism using zinc finger mediated genome editing.
    Robbez-Masson LJ; Bödör C; Jones JL; Hurst HC; Fitzgibbon J; Hart IR; Grose RP
    PLoS One; 2013; 8(11):e78839. PubMed ID: 24265722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and epigenetic mechanisms down-regulate FGF receptor 2 to induce melanoma-associated antigen A in breast cancer.
    Zhu X; Asa SL; Ezzat S
    Am J Pathol; 2010 May; 176(5):2333-43. PubMed ID: 20348248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study on genetic variants of Fibroblast growth factor receptor 2 (FGFR2) and the risk of breast cancer from North India.
    Siddiqui S; Chattopadhyay S; Akhtar MS; Najm MZ; Deo SV; Shukla NK; Husain SA
    PLoS One; 2014; 9(10):e110426. PubMed ID: 25333473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10.
    Huijts PE; van Dongen M; de Goeij MC; van Moolenbroek AJ; Blanken F; Vreeswijk MP; de Kruijf EM; Mesker WE; van Zwet EW; Tollenaar RA; Smit VT; van Asperen CJ; Devilee P
    Breast Cancer Res; 2011 Jul; 13(4):R72. PubMed ID: 21767389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic silencing through DNA and histone methylation of fibroblast growth factor receptor 2 in neoplastic pituitary cells.
    Zhu X; Lee K; Asa SL; Ezzat S
    Am J Pathol; 2007 May; 170(5):1618-28. PubMed ID: 17456767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer.
    Meyer KB; Maia AT; O'Reilly M; Teschendorff AE; Chin SF; Caldas C; Ponder BA
    PLoS Biol; 2008 May; 6(5):e108. PubMed ID: 18462018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Polymorphisms in
    Jiang Q; Mei L; Zou Y; Ding Q; Cannon RD; Chen H; Li H
    J Dent Res; 2019 Nov; 98(12):1340-1347. PubMed ID: 31509720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The breast cancer susceptibility gene product fibroblast growth factor receptor 2 serves as a scaffold for regulation of NF-κB signaling.
    Wei W; Liu W; Cassol CA; Zheng W; Asa SL; Ezzat S
    Mol Cell Biol; 2012 Nov; 32(22):4662-73. PubMed ID: 22988296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.
    Meyer KB; O'Reilly M; Michailidou K; Carlebur S; Edwards SL; French JD; Prathalingham R; Dennis J; Bolla MK; Wang Q; de Santiago I; Hopper JL; Tsimiklis H; Apicella C; Southey MC; Schmidt MK; Broeks A; Van 't Veer LJ; Hogervorst FB; Muir K; Lophatananon A; Stewart-Brown S; Siriwanarangsan P; Fasching PA; Lux MP; Ekici AB; Beckmann MW; Peto J; Dos Santos Silva I; Fletcher O; Johnson N; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; Marme F; Schneeweiss A; Sohn C; Burwinkel B; Guénel P; Truong T; Laurent-Puig P; Menegaux F; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; Milne RL; Zamora MP; Arias JI; Benitez J; Neuhausen S; Anton-Culver H; Ziogas A; Dur CC; Brenner H; Müller H; Arndt V; Stegmaier C; Meindl A; Schmutzler RK; Engel C; Ditsch N; Brauch H; Brüning T; Ko YD; ; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Matsuo K; Ito H; Iwata H; Yatabe Y; Dörk T; Helbig S; Bogdanova NV; Lindblom A; Margolin S; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Chenevix-Trench G; ; ; Wu AH; Tseng CC; Van Den Berg D; Stram DO; Lambrechts D; Thienpont B; Christiaens MR; Smeets A; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Radice P; Peterlongo P; Bonanni B; Bernard L; Couch FJ; Olson JE; Wang X; Purrington K; Giles GG; Severi G; Baglietto L; McLean C; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Simard J; Goldberg MS; Labrèche F; Dumont M; Teo SH; Yip CH; Phuah SY; Kristensen V; Grenaker Alnæs G; Børresen-Dale AL; Zheng W; Deming-Halverson S; Shrubsole M; Long J; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Kauppila S; Andrulis IL; Knight JA; Glendon G; Tchatchou S; Devilee P; Tollenaar RA; Seynaeve CM; García-Closas M; Figueroa J; Chanock SJ; Lissowska J; Czene K; Darabi H; Eriksson K; Hooning MJ; Martens JW; van den Ouweland AM; van Deurzen CH; Hall P; Li J; Liu J; Humphreys K; Shu XO; Lu W; Gao YT; Cai H; Cox A; Reed MW; Blot W; Signorello LB; Cai Q; Pharoah PD; Ghoussaini M; Harrington P; Tyrer J; Kang D; Choi JY; Park SK; Noh DY; Hartman M; Hui M; Lim WY; Buhari SA; Hamann U; Försti A; Rüdiger T; Ulmer HU; Jakubowska A; Lubinski J; Jaworska K; Durda K; Sangrajrang S; Gaborieau V; Brennan P; McKay J; Vachon C; Slager S; Fostira F; Pilarski R; Shen CY; Hsiung CN; Wu PE; Hou MF; Swerdlow A; Ashworth A; Orr N; Schoemaker MJ; Ponder BA; Dunning AM; Easton DF
    Am J Hum Genet; 2013 Dec; 93(6):1046-60. PubMed ID: 24290378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in second intron of the FGFR2 gene are associated with the risk of early-onset breast cancer in Chinese Han women.
    Fu F; Wang C; Huang M; Song C; Lin S; Huang H
    Tohoku J Exp Med; 2012 Mar; 226(3):221-9. PubMed ID: 22374580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of fibroblast growth factor receptor 2 isoform switching in mammary oncogenesis.
    Cha JY; Lambert QT; Reuther GW; Der CJ
    Mol Cancer Res; 2008 Mar; 6(3):435-45. PubMed ID: 18337450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel intronic cis element, ISE/ISS-3, regulates rat fibroblast growth factor receptor 2 splicing through activation of an upstream exon and repression of a downstream exon containing a noncanonical branch point sequence.
    Hovhannisyan RH; Carstens RP
    Mol Cell Biol; 2005 Jan; 25(1):250-63. PubMed ID: 15601847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential signal transduction of alternatively spliced FGFR2 variants expressed in human mammary epithelial cells.
    Moffa AB; Ethier SP
    J Cell Physiol; 2007 Mar; 210(3):720-31. PubMed ID: 17133345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of polymorphisms in the genes of FGFR2, FGF1, and RBFOX2 with breast cancer risk by estrogen/progesterone receptor status.
    Cen YL; Qi ML; Li HG; Su Y; Chen LJ; Lin Y; Chen WQ; Xie XM; Tang LY; Ren ZF
    Mol Carcinog; 2013 Nov; 52 Suppl 1():E52-9. PubMed ID: 23143756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of FGFR2 gene polymorphisms with the risk of breast cancer in population of West Siberia.
    Boyarskikh UA; Zarubina NA; Biltueva JA; Sinkina TV; Voronina EN; Lazarev AF; Petrova VD; Aulchenko YS; Filipenko ML
    Eur J Hum Genet; 2009 Dec; 17(12):1688-91. PubMed ID: 19536173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGFR2 isoforms support epithelial-stromal interactions in thyroid cancer progression.
    Guo M; Liu W; Serra S; Asa SL; Ezzat S
    Cancer Res; 2012 Apr; 72(8):2017-27. PubMed ID: 22345151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTBP1 promotes the progression of hepatocellular carcinoma by enhancing the oncogenic splicing switch of FGFR2.
    Chen YY; Zhang Q; Gui MH; Feng L; Cao PB; Zhou GQ
    Yi Chuan; 2024 Jan; 46(1):46-62. PubMed ID: 38230456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming potential of alternatively spliced variants of fibroblast growth factor receptor 2 in human mammary epithelial cells.
    Moffa AB; Tannheimer SL; Ethier SP
    Mol Cancer Res; 2004 Nov; 2(11):643-52. PubMed ID: 15561780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing.
    Warzecha CC; Sato TK; Nabet B; Hogenesch JB; Carstens RP
    Mol Cell; 2009 Mar; 33(5):591-601. PubMed ID: 19285943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.